Pharmacogenomics and regulatory decision making: an international perspective

Pharmacogenomics J. 2006 May-Jun;6(3):154-7. doi: 10.1038/sj.tpj.6500364.
No abstract available

MeSH terms

  • Biomarkers
  • Decision Making, Organizational*
  • Internationality*
  • Pharmacogenetics*

Substances

  • Biomarkers